Numeric Investors’s Celldex Therapeutics CLDX Stock Holding History

Numeric Investors’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.88M	Sell	44,015 -1,700	-4%	-$72.8K	0.01%	653
2017 Q3	$1.96M	Sell	45,715 -3,327	-7%	-$125K	0.02%	600
2017 Q2	$1.82M	Sell	49,042 -727	-1%	-$32.2K	0.02%	533
2017 Q1	$2.69M	Sell	49,769 -6,966	-12%	-$363K	0.02%	426
2016 Q4	$3.01M	Sell	56,735 -56,245	-50%	-$3.2M	0.03%	429
2016 Q3	$6.85M	Buy	112,980 +70,340	+165%	+$4.38M	0.06%	276
2016 Q2	$2.81M	Buy	42,640 +16,267	+62%	+$1.03M	0.03%	391
2016 Q1	$1.5M	Buy	26,373 +18,813	+249%	+$2.12M	0.02%	485
2015 Q4	$1.78M	Buy	+7,560	New	+$1.65M	0.02%	463
2015 Q3	–	Sell	-2,753	Closed	-$1.04M	–	1004
2015 Q2	$1.04M	Buy	+2,753	New	+$1.09M	0.01%	497
2015 Q1	–	Sell	-5,260	Closed	-$1.44M	–	897
2014 Q4	$1.44M	Buy	+5,260	New	+$1.31M	0.02%	390
2013 Q3	–	Sell	-1,872	Closed	-$438K	–	759
2013 Q2	$438K	Buy	+1,872	New	+$369K	0.01%	560

Other funds holding CLDX

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KLP Enterprises Branford, Connecticut $1.97M AUM

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Numeric Investors's CLDX Position: Q4 2017 in Review

Numeric Investors reduced its Celldex Therapeutics (CLDX) stake by 3.7% in Q4 2017, selling an estimated $72.8K and leaving 44,015 shares worth $1.88M. The position accounts for 0.01% of the portfolio, ranked #653.

Numeric Investors first reported a position in CLDX in Q2 2013 and has held it in 12 quarters since. The position peaked at $6.85M in Q3 2016. 135 funds tracked by Wall St. Rank hold CLDX as of Q4 2017.

Numeric Investors held 44,015 shares of Celldex Therapeutics worth $1.88M as of Q4 2017.
Numeric Investors sold 1,700 Celldex Therapeutics shares in Q4 2017, an estimated $72.8K.
Celldex Therapeutics made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #653 holding.
Numeric Investors first reported a position in Celldex Therapeutics in Q2 2013 and has held it in 12 quarters since.
Numeric Investors's Celldex Therapeutics position peaked at $6.85M in Q3 2016.
135 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.